This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of chiral molecules, which are essential for creating drugs with specific enantiomeric properties. Its application is significant in the development of central nervous system (CNS) agents, as the (R)-enantiomer often exhibits distinct biological activity compared to its (S)-counterpart. Additionally, it is employed in the study of receptor binding and enzyme inhibition, aiding in the discovery of new therapeutic compounds for neurological and psychiatric disorders. The bromophenyl group in its structure also makes it a valuable building block for further chemical modifications in medicinal chemistry.